fashion -WSS

fashion

author：entertainment 2025-10-01 12:34:58 - browse：99

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Biotech execs pursue obesity drug boom: ‘It’s the early innings’

WSS

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

CDC Director Mandy Cohen on transparency, trust, and health

How generative AI is inspiring dreams of a health data revolution

UHS says company favors patients whose insurance pays more

Why patients can’t get everything they want on drug pricing

How to protect patients from sexual assault

focus

fashion

Wikipedia

Apple is now the first public company to be valued at $3 trillion

How to fix cancer clinical trials' diversity problem

Trump demands the U.S. pay no more for drugs than other countries … again

Why patients can’t get everything they want on drug pricing

In Memoriam: Notable people who died in 2023

A rare thyroid diagnosis led to unexpected, all

Supreme Court strikes down use of affirmative action

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The battle over 'scope creep' and who gets to be called 'doctor'

Wikipedia

Truvian presents data for its desktop blood

A rare thyroid diagnosis led to unexpected, all

New Alzheimer's drugs heat up race for early detection blood tests

The haunting brain science of long Covid

Dems pitch expanding Medicare power to negotiate drug prices

A new crop of companies is reshaping the health data economy

knowledge

focus

knowledge

leisure time